{"database": "lobbying", "table": "lobbying_activities", "rows": [[2350133, "021e5079-612e-48fd-bb08-0f1ea6df6f4b", "Q3", "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 3457, "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 2019, "third_quarter", "PHA", "Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Support for S. 340/H.R. 965, Creating and Restoring Equal Access to Equivalent Samples Act of 2019. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", null, 350000, 0, 0, "2019-10-18T10:53:08.447000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2350133"], "units": {}, "query_ms": 48.33141295239329, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}